Literature DB >> 27430683

Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.

Bernhard F Décard1, Jan Thöne2, Aiden Haghikia3, Christian Börnke3, Agnes Anders4, Carsten Lukas5, Ralf Gold3.   

Abstract

BACKGROUND: Listeriosis caused by listeria monocytogenes (LM) is a potentially lethal foodborne infection of the central nervous system (CNS) and the third most common cause of bacterial meningitis. Foods most commonly implicated are soft cheeses, raw or ready-to-eat meat and pre-processed foods. The incubation time is between 11 and 70 days. Rarely LM rhombencephalitis (RE) can occur, which typically has a biphasic course with non- specific prodromal symptoms like fever, malaise, fatigue, headache, nausea and vomiting followed by cranial nerve palsies, ataxia and hemi- or tetraparesis.
OBJECTIVE: To report a 31-year old immunocompetent female developing a severe abscessing RE caused by LM, which was initially assessed as a relapse after a clinically isolated syndrome (CIS).
METHODS: Case report.
RESULTS: Patients with CIS or multiple sclerosis, who present with brainstem symptoms should be evaluated carefully. The presence of clinical and paraclinical red flags in the diagnostic evaluation of a suspected CNS white matter disease should raise the awareness of clinicians for potential differential diagnoses.

Entities:  

Keywords:  Listeria monocytogenes; alemtuzumab; brainstem; clinically isolated syndrome; multiple sclerosis; rhombencephalitis

Mesh:

Year:  2016        PMID: 27430683     DOI: 10.1177/1352458516650522

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  5 in total

Review 1.  Early trigeminal nerve involvement in Listeria monocytogenes rhombencephalitis: case series and systematic review.

Authors:  William K Karlsson; Zitta Barrella Harboe; Casper Roed; Jeppe B Monrad; Mette Lindelof; Vibeke Andrée Larsen; Daniel Kondziella
Journal:  J Neurol       Date:  2017-07-20       Impact factor: 4.849

Review 2.  Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program.

Authors:  Eva Havrdova; Jeffrey A Cohen; Dana Horakova; Ivana Kovarova; Eva Meluzinova
Journal:  Ther Clin Risk Manag       Date:  2017-10-16       Impact factor: 2.423

Review 3.  Severe invasive Listeria monocytogenes rhombencephalitis mimicking facial neuritis in a healthy middle-aged man: a case report and literature review.

Authors:  Liming Cao; Yanwei Lin; Hongliang Jiang; Jiehong Wei
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

4.  Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world.

Authors:  Tjalf Ziemssen; Katja Thomas
Journal:  Ther Adv Neurol Disord       Date:  2017-08-04       Impact factor: 6.570

Review 5.  Rhombencephalitis due to Listeria monocytogenes infection with GQ1b antibody positivity and multiple intracranial hemorrhage: a case report and literature review.

Authors:  Yingying Zhao; Chunling Xu; Houzhen Tuo; Ye Liu; Jiali Wang
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.